| Identification | |
| Name: | Febuxostat |
| Synonyms: | 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-;Tei 6720;Febuxostat/ 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid;Febuxostat (JAN/USAN);TMX 67;Tei-6720;2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;TMX-67; |
| CAS: | 144060-53-7 |
| Molecular Formula: | C16H16N2O3S |
| Molecular Weight: | 316.37 |
| InChI: | InChI=1/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.31 g/cm3 |
| Refractive index: | 1.605 |
| Appearance: | Crystalline Solid |
| Usage: | Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout |
| Safety Data | |
 |
|
